The MHRA Papers - Part 1
How do you measure infectiousness?
The minutes of the first three meetings of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert Working Group between 25 August and 14 October 2020 are relatively sparse in riveting details.
They are mainly concerned with organisational details, but several redactions, especially in parts of members' disclosure statement…